P13K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant CancersWEE, Susan; JAGANI, Zainab; XIAOQIN XIANG, Kay et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 10, pp 4286-4293, issn 0008-5472, 8 p.Article

C-jun n-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivoZHILI SHAO; BHATTACHARYA, Kausik; NAMCHUK, Mark et al.Circulation research. 2006, Vol 98, Num 1, pp 111-118, issn 0009-7330, 8 p.Article

Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell LymphomasNAYLOR, Tara L; HUAPING TANG; YAO, Yung-Mae et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 7, pp 2643-2653, issn 0008-5472, 11 p.Article

Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: defining molecular mechanisms of resistanceSHAO, Wenlin; GROWNEY, Joseph D; YUN FENG et al.International journal of cancer (Print). 2010, Vol 127, Num 9, pp 2199-2208, issn 0020-7136, 10 p.Article

In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myelomaOCIO, Enrique M; VILANOVA, David; SHAO, Wenlin et al.Haematologica (Roma). 2010, Vol 95, Num 5, pp 794-803, issn 0390-6078, 10 p.Article

The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma CellsJAGANI, Zainab; WIEDERSCHAIN, Dmitri; WARMUTH, Markus et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 13, pp 5528-5538, issn 0008-5472, 11 p.Article